These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 1383012

  • 1. Effects of N-ethyl,N-nitrosourea on monoamine concentrations and metabolizing enzymes in mouse brain regions.
    Jayasekara S, Sharma RP, Drown DB.
    Eur J Pharmacol; 1992 May 01; 228(1):37-44. PubMed ID: 1383012
    [Abstract] [Full Text] [Related]

  • 2. Effects of benzo[a]pyrene on steady-state levels of biogenic amines and metabolizing enzymes in mouse brain regions.
    Jayasekara S, Sharma RP, Drown DB.
    Ecotoxicol Environ Saf; 1992 Aug 01; 24(1):1-12. PubMed ID: 1385071
    [Abstract] [Full Text] [Related]

  • 3. Modification of gonadectomy-induced increases in brain monoamine metabolism by steroid hormones in male and female rats.
    Bitar MS, Ota M, Linnoila M, Shapiro BH.
    Psychoneuroendocrinology; 1991 Aug 01; 16(6):547-57. PubMed ID: 1725825
    [Abstract] [Full Text] [Related]

  • 4. Alteration of biogenic amines in mouse brain regions by alkylating agents. I. Effects of aflatoxin B1 on brain monoamines concentrations and activities of metabolizing enzymes.
    Jayasekara S, Drown DB, Coulombe RA, Sharma RP.
    Arch Environ Contam Toxicol; 1989 Aug 01; 18(3):396-403. PubMed ID: 2499275
    [Abstract] [Full Text] [Related]

  • 5. Effect of repeated dietary exposure of aflatoxin B1 on brain biogenic amines and metabolites in the rat.
    Coulombe RA, Sharma RP.
    Toxicol Appl Pharmacol; 1985 Sep 30; 80(3):496-501. PubMed ID: 2412309
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fumonisin B1-induced increases in neurotransmitter metabolite levels in different brain regions of BALB/c mice.
    Tsunoda M, Dugyala RR, Sharma RP.
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Oct 30; 120(3):457-65. PubMed ID: 9827064
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of neuropeptide Y (NPY) and [D-Trp32]NPY on monoamine and metabolite levels in dialysates from rat hypothalamus during feeding behavior.
    Matos FF, Guss V, Korpinen C.
    Neuropeptides; 1996 Aug 30; 30(4):391-8. PubMed ID: 8914867
    [Abstract] [Full Text] [Related]

  • 12. Effects of dietary vanadium exposure on levels of regional brain neurotransmitters and their metabolites.
    Sharma RP, Coulombe RA, Srisuchart B.
    Biochem Pharmacol; 1986 Feb 01; 35(3):461-5. PubMed ID: 2418840
    [Abstract] [Full Text] [Related]

  • 13. Alteration of the turnover of dopamine and 5-hydroxytryptamine in rat brain associated with hypothermia.
    Okuda C, Saito A, Miyazaki M, Kuriyama K.
    Pharmacol Biochem Behav; 1986 Jan 01; 24(1):79-83. PubMed ID: 2418447
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rapid determination of norepinephrine, dopamine, serotonin, their precursor amino acids, and related metabolites in discrete brain areas of mice within ten minutes by HPLC with electrochemical detection.
    Murai S, Saito H, Masuda Y, Itoh T.
    J Neurochem; 1988 Feb 01; 50(2):473-9. PubMed ID: 2447240
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids.
    Thiblin I, Finn A, Ross SB, Stenfors C.
    Br J Pharmacol; 1999 Mar 01; 126(6):1301-6. PubMed ID: 10217522
    [Abstract] [Full Text] [Related]

  • 19. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.
    Irifune M, Fukuda T, Nomoto M, Sato T, Kamata Y, Nishikawa T, Mietani W, Yokoyama K, Sugiyama K, Kawahara M.
    Brain Res; 1997 Jul 25; 763(2):281-4. PubMed ID: 9296573
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.